In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 10, 1996, Pages 2431-2433

  Barry, Arthur L ^a   Fuchs, Peter C ^a   Brown, Steven D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 6 FLUORO 1,4 DIHYDRO 4 OXO 1,8 NAPHTHYRIDINE 3 CARBOXYLIC ACID; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINAFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; TROVAFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0029797531     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.10.2431     Document Type: Article

References (12)

1. Baquero, F. 1995. Pneumococcal resistance to β-lactam antibiotics: a global geographic overview, Microb. Drug Resistance 1:115-121.
2. Cooper, B., and M. Lowler. 1989. Pneumococcal bacteremia during ciprofloxacin therapy for pneumococcal pneumonia. Am. J. Med. 87:475.
3. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
4. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15:119-127.
5. Lee, B. L., A. M. Padula, R. C. Kimbrough, S. R. Jones, R. E. Chaisson, J. Mills, and M. A. Sande. 1991. Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N. Engl. J. Med. 325:520-521.
6. Linares, J., T. Alonso, J. L. Perez, J. Ayats, M. A. Domenquez, R. Pallares, and R. Martin. 1992. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J. Antimicrob. Chemother. 30: 279-288.
7. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests of bacteria that grow aerobically. Approved standard M7-A3, 3rd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Neal, T. J., M. A. T. O'Donoghue, I. F. Ridgeway, and K. D. Allen. 1992. In vitro activity of ten antimicrobial agents against penicillin-resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 30:39-46.
9. Perez-Trallero, E., J. M. Garcia-Arenzana, and A. Peris. 1990. Therapeutic failures and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 9:905-906.
10. Soriano, F., and R. Fernandez-Roblas. 1993. High rates of erythromycin-resistant Streptococcus pneumoniae among penicillin-resistant strains. J. Antimicrob. Chcmother. 31:440.
11. Tarpay, M. M., D. F. Welch, H. Salari, and M. I. Marks. 1982. In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob. Agents Chemother. 22:145-147.
12. Thys, J. P., B. Jacobs, and B. Byl. 1991. Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 10:304-315.